Our Pricing

Understanding Ozempic vs Mounjaro Monthly Cost in the UK

When comparing ozempic vs mounjaro monthly cost uk options, understanding both price and clinical outcomes helps you make an informed choice. At Cured Pharmacy, we offer transparent upfront pricing on both medications, with Mounjaro available from £135.00 per month and free clinical consultations from UK-registered prescribers to determine which treatment suits your weight loss goals.

Ozempic vs Mounjaro Monthly Cost UK: Price Breakdown

The monthly cost for weight loss injections in the UK varies significantly based on the medication, dosage strength, and pharmacy pricing structure. At Cured Pharmacy, Mounjaro (tirzepatide) starts from £135.00 per month, offering competitive UK pricing with transparent costs shown before your consultation begins.

While Ozempic (semaglutide) is primarily licensed in the UK for type 2 diabetes management rather than weight loss, many patients seek cost comparisons between these two injectable treatments. The monthly cost depends on your prescribed maintenance dose, which your UK prescriber determines based on your clinical response and tolerance during the titration period.

It's worth noting that the lowest price doesn't always represent the best value. Clinical trial data shows tirzepatide achieved superior weight loss outcomes compared to semaglutide, with patients in the SURPASS-2 trial experiencing up to 22.5% body weight reduction over 72 weeks on the highest dose [1]. When evaluating monthly costs, consider both the financial investment and the clinical efficacy demonstrated in peer-reviewed research.

How Mounjaro and Ozempic Work Differently

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA in the UK [2]. This dual mechanism activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, creating a synergistic effect on appetite regulation, insulin secretion, and energy expenditure.

Ozempic contains semaglutide, a single-pathway GLP-1 receptor agonist originally developed for type 2 diabetes. While semaglutide effectively reduces appetite and slows gastric emptying through GLP-1 activation alone, the addition of GIP receptor activation in tirzepatide appears to enhance weight loss outcomes significantly [1][2].

In head-to-head clinical trials, tirzepatide demonstrated superior efficacy. The SURPASS-2 study directly compared tirzepatide against semaglutide 1mg in patients with type 2 diabetes, showing that the highest tirzepatide dose (15mg) produced approximately 5.5kg more weight loss than semaglutide over 40 weeks [1]. This mechanistic difference explains why many UK prescribers now consider Mounjaro when patients require more substantial weight reduction, subject to clinical assessment and suitability.

Clinical Trial Evidence: SURPASS and SURMOUNT Studies

The SURPASS clinical trial programme evaluated tirzepatide across multiple studies involving over 10,000 participants with type 2 diabetes. In SURPASS-3, participants achieved average body weight reductions of 15.0kg, 19.5kg, and 20.9kg on the 5mg, 10mg, and 15mg doses respectively over 72 weeks [3]. The SURMOUNT-1 trial specifically examined tirzepatide for weight management in adults without diabetes, demonstrating average weight loss up to 22.5% of baseline body weight on the 15mg dose [4].

For context, the STEP trial programme for semaglutide showed impressive results as well, with STEP 1 participants achieving average weight loss of 14.9% on the 2.4mg dose over 68 weeks [5]. Both medications represent significant advances in pharmacological weight management, though the dual-receptor mechanism in tirzepatide appears to confer additional clinical benefit in many patients, subject to individual response and prescriber assessment.

Factors Affecting Your Monthly Cost

Your monthly cost for either medication depends primarily on your prescribed maintenance dose. Both Mounjaro and Ozempic follow dose titration schedules, starting at lower doses and gradually increasing every four weeks to minimise gastrointestinal side effects. Your UK prescriber determines your optimal maintenance dose based on your weight loss response, tolerability, and clinical goals.

For Mounjaro, the licensed dosing schedule begins at 2.5mg weekly for four weeks, then increases to 5mg. Further increases to 7.5mg, 10mg, 12.5mg, and finally 15mg occur at four-week intervals if additional weight loss is needed and the medication is well-tolerated [2]. Your monthly cost reflects whichever dose you're prescribed for ongoing treatment.

Additional factors influencing your overall investment include consultation fees (free at Cured Pharmacy), delivery charges, and whether you purchase single pens or multi-month supplies. Some patients find that purchasing several months together reduces per-month costs, though this requires upfront payment and assumes your dose remains stable throughout that period.

Comparing Value: Clinical Outcomes vs Monthly Investment

When evaluating ozempic vs mounjaro monthly cost uk options, clinical value extends beyond the price tag. Patients in tirzepatide trials achieved their target weight loss outcomes more quickly and with greater magnitude than those on semaglutide, potentially reducing the total duration of treatment required [1][4].

From a health economics perspective, greater weight loss correlates with more substantial improvements in obesity-related comorbidities. SURPASS trial participants experienced meaningful reductions in HbA1c, blood pressure, and lipid profiles alongside their weight loss [3]. These metabolic improvements may reduce long-term healthcare costs associated with type 2 diabetes, cardiovascular disease, and other obesity-related conditions.

Your UK prescriber can help you weigh these factors during your consultation. For some patients, a lower monthly cost with slower weight loss progression represents the right choice. For others, investing in a more potent treatment that delivers faster, more substantial results proves more cost-effective over the full treatment course. Both approaches are clinically valid, subject to individual circumstances and prescriber recommendation.

What's Included in Your Cured Pharmacy Price

At Cured Pharmacy, our transparent pricing includes the medication itself, free online consultation with a UK-registered prescriber, clinical review of your medical history and current medications, and discreet delivery to your preferred UK address. There are no hidden consultation fees or unexpected charges at checkout.

All prescription weight loss medications dispensed by Cured Pharmacy are genuine, UK-licensed products sourced through regulated pharmaceutical supply chains. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees dispensing to ensure every patient receives authentic medication that meets MHRA quality standards. Your treatment is subject to clinical approval following assessment by our UK prescribing team.

Alternative Weight Loss Treatments and Costs

Beyond Mounjaro and Ozempic, several other prescription weight loss treatments are available through UK pharmacies, each with different mechanisms, administration methods, and price points. Wegovy (semaglutide 2.4mg) is the higher-dose formulation of the same active ingredient found in Ozempic, specifically licensed for weight management rather than diabetes [5]. At Cured Pharmacy, Wegovy is available from £135.00 per month, offering a lower-cost semaglutide option for eligible patients.

Saxenda (liraglutide) represents an earlier-generation GLP-1 receptor agonist requiring daily injections rather than weekly administration. Available from £135.00 per month at Cured Pharmacy, Saxenda suits patients who prefer lower upfront costs or who may not tolerate the longer-acting formulations. Clinical trials showed average weight loss of 8% over 56 weeks, which is meaningful though generally less than the newer weekly injections [6].

For patients seeking non-injectable options, oral medications like Orlistat work through a completely different mechanism by blocking fat absorption in the digestive system. Available from £135.00 per month at Cured Pharmacy, Orlistat represents the most affordable prescription weight loss option, though clinical outcomes are typically more modest than injectable GLP-1 treatments. Your UK prescriber will discuss which treatment aligns with your clinical profile, lifestyle preferences, and budget during your free consultation.

How to Start Treatment at Cured Pharmacy

Beginning your weight loss treatment journey at Cured Pharmacy takes under three minutes through our online consultation platform. You'll answer questions about your medical history, current medications, weight loss goals, and any previous weight management attempts. This information allows our UK-registered prescribers to assess whether Mounjaro, Wegovy, or another treatment is clinically appropriate for you.

If approved, your prescription is sent electronically to our dispensing team, and your medication is prepared for discreet delivery to your UK address. We use plain, unmarked packaging to protect your privacy, with no external indication of the contents. Most patients receive their first delivery within 2-4 working days of prescription approval.

Ongoing treatment includes regular check-ins with our clinical team to monitor your progress, adjust dosing as needed, and address any questions or concerns. Our pharmacists are available by phone on (+44) 116 4646009 during business hours if you need advice about administration technique, side effect management, or prescription renewals. All follow-up consultations are included in your treatment cost, ensuring continuous clinical support throughout your weight loss programme.

What to Expect During Dose Titration

Both Mounjaro and Ozempic require gradual dose increases over several months to reach your maintenance dose. This titration schedule minimises common gastrointestinal side effects like nausea, which typically improve as your body adjusts to each dose level. Your prescriber will provide a clear schedule showing when to increase your dose and what to expect at each stage.

During titration, some patients notice appetite reduction and modest weight loss even on the starter doses, while others experience more significant effects only after reaching higher doses. This individual variation is normal and doesn't predict your final outcome. Your UK prescriber may adjust the titration speed based on your tolerance and response, ensuring you reach an effective dose safely and comfortably.

Scientific References

1. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. GOV.UK. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
3. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
6. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.